🧬 U.S. Tissue Diagnostics Market Insights (2026–2035)
The U.S. Tissue Diagnostics Market was valued at USD 3.25B in 2025 and is projected to reach USD 4.78B by 2035, growing at a CAGR of 3.94%.
The U.S. tissue diagnostics market size was valued at USD 3.25 billion in 2025 and is expected to hit around USD 4.78 billion by 2035 with a
🔎 Key Highlights:
• Immunohistochemistry (IHC) led the market with 35.02% share in 2025 • Breast cancer dominated applications with 56%+ revenue share • Gastric cancer segment expected to grow at 4.03% CAGR • Digital pathology & AI integration accelerating adoption
📈 Growth Drivers:
✔ Rising cancer incidence (~2M new U.S. cases annually) ✔ Growing demand for precision & companion diagnostics ✔ Expansion of AI-powered digital pathology ✔ Increased adoption of minimally invasive biopsy techniques
